Skip to content

Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas

Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas: The LOG-Glio-Project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02686229
Acronym
LoG-Glio
Enrollment
300
Registered
2016-02-19
Start date
2015-11-15
Completion date
2036-12-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Keywords

Low grade glioma, registry, neurosurgery, brain tumor

Brief summary

The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.

Interventions

OTHERno interventions

Sponsors

Charite University, Berlin, Germany
CollaboratorOTHER
University of Ulm
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with radiological suspected diagnosis of a low grade glioma * Age ≥ 18 years. There is no upper age limit.

Exclusion criteria

* Severe neurological or psychiatric disorder interfering with ability to give an informed consent * No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation * No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.

Design outcomes

Primary

MeasureTime frame
Progression-free survival (PFS)5yrs
Overall survival (OS)15yrs

Secondary

MeasureTime frameDescription
Extent of tumor resection3yrscalculated based on volumetric assessement of tumor in cm³ and residual tumor in pre and postoperative MRI
Quality of life (QoL) assessed by the EORTC QLQ C-30/BN-20. (European Organisation for Research and Treatment of Cancer Quality of Life Questionaire C-305yrs

Countries

Germany

Contacts

Primary ContactJan Coburge, MD
jan.coburger@uni-ulm.de082219628858

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026